Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression

Journal of Clinical Oncology

Volumn 17, Issue 1, 1999, Pages 304-311

  Palmieri, Giuseppe ^a   Strazzullo, Maria ^a   Ascierto, Paolo A ^a   Satriano, Sabrina M R ^a   Daponte, Antonio ^a   Castello, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; MARKER GENE; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 0032923934     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.1.304     Document Type: Article

References (33)

1. Schuchter LM: Melanoma and other skin neoplasms. Curr Opin Oncol 9:175-177, 1997
2. Berwick M, Halpern AH: Melanoma epidemiology. Curr Opin Oncol 9:178-182, 1997
3. Smith B, Selby P, Southgate J, et al: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229, 1991
4. Brichard V, Van Pel A, Wolfel T, et al: The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178:489-495, 1993
5. Brossart P, Keilholz U, Willhauck M, et al: Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101:887-889, 1993
6. Brossart P, Keilholz U, Scheibenbogen C, et al: Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy. J Immunother 15:38-41, 1994
7. Brossart P, Schmier J, Kruger S, et al: A PCR-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55:4065-4068, 1995
8. Foss AJ, Guille MJ, Occleston NL, et al: The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 72:155-159, 1995
9. Battayani Z, Grob J, Xerri R, et al: PCR detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 131:443-447, 1995
10. Kunter U, Buer J, Probst M, et al: Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88:590-594, 1996
11. Stevens GL, Scheer WD, Levine EA: Detection of tyrosinase mRNA from the blood of melanoma patients. Cancer Epidemiol Biomarkers Prev 5:293-296, 1996
12. Pittman K, Burchill S, Smith B, et al: Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 7:297-301, 1996
13. Reinhold U, Ludtke Handjery HC, Schnautz S, et al: The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 108:166-169, 1997
14. Mellado B, Colomer D, Castel T, et al: Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis. J Clin Oncol 14:2091-2097, 1996
15. Proebstle T, Voit C, Weber W, et al: Association of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, disease-free survival and other risk factors. Symposium, Diagnostic PCR in Oncology. Heidelberg, Germany, 1997 (abstract 22)
16. Glaser R, Rass K, Seiter S, et al: Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study. J Clin Oncol 15:2818-2825, 1997
17. Jung FA, Buzaid AC, Ross MI, et al: Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. J Clin Oncol 15:2826-2831, 1997
18. Keilholz U: Diagnostic PCR in melanoma, methods and quality assurance. Epalinges, Switzerland, 26/27 January 1996. Eur J Cancer 32A:1661-1663, 1996
19. Hoon DSB, Wang Y, Dale PS, et al: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-2116, 1995
20. Sarantou T, Chi DDJ, Garrison DA, et al: Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 57:1371-1376, 1997
21. Rose TM, Plowman GD, Teplow DB, et al: Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc Natl Acad Sci USA 83:1261-1265, 1986
22. Lehmann JM, Riethmuller G, Johnson JP: MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 86:9891-9895, 1989
23. Coulie PG, Brichard V, Van Pel A, et al: A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180:35-42, 1994
24. Slingluff CL Jr, Hunt DF, Engelhard VH: Direct analysis of tumor-associated peptide antigens. Curr Opin Immunol 6:733-740, 1994
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
26. Maniatis T, Fritsch EF, Sambrook J (eds): Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
27. Palmieri G, Romano G, Ciccodicola A, et al: YAC contig organization and CpG island analysis in Xq28. Genomics 24:149-158, 1994
28. Breslow A: Thickness, cross-sectional area and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902-908, 1970
29. Clark WH Jr, Elder DE, Guerry D IV, et al: A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15:1147-1165, 1984
30. Gaugler B, Van den Eynde B, van der Bruggen P, et al: Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921-930, 1994
31. Bakker AB, Schreurs MWJ, de Boer AJ, et al: Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179:1005-1009, 1994
32. Brouwenstijn N, Slager EH, Bakker AB, et al: Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage. Br J Cancer 76:1562-1566, 1997
33. de Vries TJ, Fourkour A, Wobbes T, et al: Heterogeneous expression of immunotherapy candidate proteins gp100, MART1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 57:3223-3229, 1997